IMPROVED AORTOCORONARY BYPASS PATENCY BY LOW-DOSE ASPIRIN (100 mg DAILY)

Reinhard Lorenz, Michael A. Weber, J. Kotzur, K. Theisen, C. von Schacky, W Meister, Bärbel Reichardt, Christian Weber

The Lancet

June 1, 1984

10.1016/s0140-6736(84)92446-2

Cited by 320

Abstract

Related Papers

An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation

Salvador Moncada, Ryszard J. Gryglewski, S Bunting et al.|Nature|1976|3.6k

Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides.

Mats Hámberg, Jan Olof Svensson, B Samuelsson|Proceedings of the National Academy of Sciences|1975|3.1k

ON ESTIMATING THE RELATION BETWEEN BLOOD GROUP AND DISEASE

Barnet Woolf|Annals of Human Genetics|1955|2.7k

Effect of Dipyridamole and Aspirin on Late Vein-Graft Patency after Coronary Bypass Operations

James H. Chesebro, Valentı́n Fuster, Lila R. Elveback et al.|New England Journal of Medicine|1984|523

DIFFERENTIAL INHIBITION OF PROSTACYCLIN PRODUCTION AND PLATELET AGGREGATION BY ASPIRIN

Giulio Masotti, Loredana Poggesi, Giorgio Galanti et al.|The Lancet|1979|285